Fluoxetinum [Inn-Latin] en es it fr

Fluoxetinum [Inn-Latin] Brand names, Fluoxetinum [Inn-Latin] Analogs

Fluoxetinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Fluoxetinum [Inn-Latin] Chemical_Formula


Fluoxetinum [Inn-Latin] RX_link


Fluoxetinum [Inn-Latin] fda sheet

Fluoxetinum_[Inn-Latin] FDA

Fluoxetinum [Inn-Latin] msds (material safety sheet)

Fluoxetinum_[Inn-Latin] MSDS

Fluoxetinum [Inn-Latin] Synthesis Reference

B. B. Mally; K. K. Schmiegel; U.S. Pat. 4,314,081 (1982)

Fluoxetinum [Inn-Latin] Molecular Weight

309.326 g/mol

Fluoxetinum [Inn-Latin] Melting Point


Fluoxetinum [Inn-Latin] H2O Solubility

50 mg/mL at 25°C

Fluoxetinum [Inn-Latin] State


Fluoxetinum [Inn-Latin] LogP


Fluoxetinum [Inn-Latin] Dosage Forms

Capsule; Liquid; Solution

Fluoxetinum [Inn-Latin] Indication

For the treatment of depression, obsessive compulsive disorder, and bulimia nervosa.

Fluoxetinum [Inn-Latin] Pharmacology

Fluoxetine, an antidepressant agent belonging to the selective serotonin reuptake inhibitors (SSRIs), is used to treat depression, bulimia nervosa, premenstrual dysphoric disorder, panic disorder and post-traumatic stress. According to the amines hypothesis, a functional decrease in the activity of amines, such as serotonin and norepinephrine, would result in depression; a functional increase of the activity of these amines would result in mood elevation. Fluoxetine's effects are thought to be associated with the inhibition of 5HT receptor, which leads to an increase of serotonin level.

Fluoxetinum [Inn-Latin] Absorption


Fluoxetinum [Inn-Latin] side effects and Toxicity

Symptoms of overdose include agitation, restlessness, hypomania, and other signs of CNS excitation. LD50=284mg/kg (orally in mice).

Fluoxetinum [Inn-Latin] Patient Information

Fluoxetinum [Inn-Latin] Organisms Affected

Humans and other mammals